FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2127218037> ?p ?o ?g. }

• W2127218037 abstract "Taurolidin/Citrate (TauroLock™), a lock solution with broad spectrum antimicrobial activity, may prevent bloodstream infection (BSI) due to coagulase-negative staphylococci (CoNS or 'MRSE' in case of methicillin-resistant isolates) in pediatric cancer patients with a long term central venous access device (CVAD, Port- or/Broviac-/Hickman-catheter type). In a single center prospective 48-months cohort study we compared all patients receiving anticancer chemotherapy from April 2003 to March 2005 (group 1, heparin lock with 200 IU/ml sterile normal saline 0.9%; Canusal® Wockhardt UK Ltd, Wrexham, Wales) and all patients from April 2005 to March 2007 (group 2; taurolidine 1.35%/Sodium Citrate 4%; TauroLock™, Tauropharm, Waldbüttelbrunn, Germany). In group 1 (heparin), 90 patients had 98 CVAD in use during the surveillance period. 14 of 30 (47%) BSI were 'primary Gram positive BSI due to CoNS (n = 4) or MRSE (n = 10)' [incidence density (ID); 2.30 per 1000 inpatient CVAD-utilization days]. In group 2 (TauroLock™), 89 patients had 95 CVAD in use during the surveillance period. 3 of 25 (12%) BSI were caused by CoNS. (ID, 0.45). The difference in the ID between the two groups was statistically significant (P = 0.004). The use of Taurolidin/Citrate (TauroLock™) significantly reduced the number and incidence density of primary catheter-associated BSI due to CoNS and MRSE in pediatric cancer patients." @default.
• W2127218037 created "2016-06-24" @default.
• W2127218037 creator A5006193393 @default.
• W2127218037 creator A5014418720 @default.
• W2127218037 creator A5027639619 @default.
• W2127218037 creator A5070958217 @default.
• W2127218037 creator A5074936670 @default.
• W2127218037 creator A5082193469 @default.
• W2127218037 date "2008-07-29" @default.
• W2127218037 modified "2023-10-09" @default.
• W2127218037 title "Taurolidine-citrate lock solution (TauroLock) significantly reduces CVAD-associated grampositive infections in pediatric cancer patients" @default.
• W2127218037 cites W1910747023 @default.
• W2127218037 cites W1967725621 @default.
• W2127218037 cites W1983020162 @default.
• W2127218037 cites W1994066619 @default.
• W2127218037 cites W1997308534 @default.
• W2127218037 cites W1999005097 @default.
• W2127218037 cites W2007203175 @default.
• W2127218037 cites W2015369262 @default.
• W2127218037 cites W2020480134 @default.
• W2127218037 cites W2026127694 @default.
• W2127218037 cites W2026175036 @default.
• W2127218037 cites W2044277716 @default.
• W2127218037 cites W2044526528 @default.
• W2127218037 cites W2059426530 @default.
• W2127218037 cites W2060833090 @default.
• W2127218037 cites W2063828844 @default.
• W2127218037 cites W2068138351 @default.
• W2127218037 cites W2069001365 @default.
• W2127218037 cites W2077189983 @default.
• W2127218037 cites W2079804991 @default.
• W2127218037 cites W2085252968 @default.
• W2127218037 cites W2106619135 @default.
• W2127218037 cites W2112145906 @default.
• W2127218037 cites W2115310210 @default.
• W2127218037 cites W2117720032 @default.
• W2127218037 cites W2130892368 @default.
• W2127218037 cites W2135554115 @default.
• W2127218037 cites W2137954811 @default.
• W2127218037 cites W2141033593 @default.
• W2127218037 cites W2145413194 @default.
• W2127218037 cites W2154637040 @default.
• W2127218037 cites W2157394348 @default.
• W2127218037 cites W2159547379 @default.
• W2127218037 cites W2164295804 @default.
• W2127218037 cites W51193635 @default.
• W2127218037 doi "https://doi.org/10.1186/1471-2334-8-102" @default.
• W2127218037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2515312" @default.
• W2127218037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18664278" @default.
• W2127218037 hasPublicationYear "2008" @default.
• W2127218037 type Work @default.
• W2127218037 sameAs 2127218037 @default.
• W2127218037 citedByCount "79" @default.
• W2127218037 countsByYear W21272180372012 @default.
• W2127218037 countsByYear W21272180372013 @default.
• W2127218037 countsByYear W21272180372014 @default.
• W2127218037 countsByYear W21272180372015 @default.
• W2127218037 countsByYear W21272180372016 @default.
• W2127218037 countsByYear W21272180372017 @default.
• W2127218037 countsByYear W21272180372018 @default.
• W2127218037 countsByYear W21272180372019 @default.
• W2127218037 countsByYear W21272180372020 @default.
• W2127218037 countsByYear W21272180372021 @default.
• W2127218037 countsByYear W21272180372022 @default.
• W2127218037 countsByYear W21272180372023 @default.
• W2127218037 crossrefType "journal-article" @default.
• W2127218037 hasAuthorship W2127218037A5006193393 @default.
• W2127218037 hasAuthorship W2127218037A5014418720 @default.
• W2127218037 hasAuthorship W2127218037A5027639619 @default.
• W2127218037 hasAuthorship W2127218037A5070958217 @default.
• W2127218037 hasAuthorship W2127218037A5074936670 @default.
• W2127218037 hasAuthorship W2127218037A5082193469 @default.
• W2127218037 hasBestOaLocation W21272180371 @default.
• W2127218037 hasConcept C120665830 @default.
• W2127218037 hasConcept C121332964 @default.
• W2127218037 hasConcept C126322002 @default.
• W2127218037 hasConcept C141071460 @default.
• W2127218037 hasConcept C2777557582 @default.
• W2127218037 hasConcept C2778446481 @default.
• W2127218037 hasConcept C2780446839 @default.
• W2127218037 hasConcept C2781267111 @default.
• W2127218037 hasConcept C3018946976 @default.
• W2127218037 hasConcept C61511704 @default.
• W2127218037 hasConcept C71924100 @default.
• W2127218037 hasConceptScore W2127218037C120665830 @default.
• W2127218037 hasConceptScore W2127218037C121332964 @default.
• W2127218037 hasConceptScore W2127218037C126322002 @default.
• W2127218037 hasConceptScore W2127218037C141071460 @default.
• W2127218037 hasConceptScore W2127218037C2777557582 @default.
• W2127218037 hasConceptScore W2127218037C2778446481 @default.
• W2127218037 hasConceptScore W2127218037C2780446839 @default.
• W2127218037 hasConceptScore W2127218037C2781267111 @default.
• W2127218037 hasConceptScore W2127218037C3018946976 @default.
• W2127218037 hasConceptScore W2127218037C61511704 @default.
• W2127218037 hasConceptScore W2127218037C71924100 @default.
• W2127218037 hasIssue "1" @default.
• W2127218037 hasLocation W21272180371 @default.
• W2127218037 hasLocation W21272180372 @default.
• W2127218037 hasLocation W21272180373 @default.
• W2127218037 hasLocation W21272180374 @default.

• next